The cGAS-STING pathway: a dual regulator of immune response in cancer and therapeutic implications

Area of Science:

• Immunology
• Molecular Biology
• Oncology

Background:

• The cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) pathway is crucial for innate immunity, detecting cytoplasmic DNA and initiating inflammatory responses.
• This pathway plays a complex role in cancer, influencing both anti-tumor immunity and immune evasion mechanisms like PD-L1 upregulation.
• Factors such as autophagy, oxidative stress, and DNA damage modulate cGAS-STING signaling, impacting tumor progression and host defense.

Purpose of the Study:

• To elucidate the multifaceted roles of the cGAS-STING pathway in cancer immunity and progression.
• To explore how cellular processes like autophagy and post-translational modifications influence cGAS-STING activity.
• To identify therapeutic strategies that harness the immunostimulatory potential of cGAS-STING while overcoming immune suppression.

Main Methods:

• Review and synthesis of existing literature on cGAS-STING pathway signaling in cancer.
• Analysis of the interplay between cGAS-STING, autophagy, DNA damage, and immune checkpoints.
• Investigation of post-translational modifications (e.g., m6A methylation, acetylation) affecting cGAS-STING function.

Main Results:

• The cGAS-STING pathway exhibits dual functionality, promoting anti-tumor immunity but also driving immune evasion via PD-L1.
• Autophagy and phase separation enhance cGAS signaling, impacting tumor proliferation and DNA sensing.
• Oxidative stress and DNA damage activate cGAS-STING, leading to inflammation and potential metabolic disorders.
• Combined therapies targeting DNA damage response and immune checkpoints show promise for enhancing anti-tumor immunity.
• Post-translational modifications fine-tune cGAS-STING activity and downstream signaling.

Conclusions:

• The cGAS-STING pathway presents a complex therapeutic target in cancer due to its dual pro- and anti-tumorigenic roles.
• Targeted interventions can leverage cGAS-STING's immunostimulatory effects while mitigating immune escape mechanisms.
• The pathway's link to inflammation and metabolic dysfunction highlights its broader clinical relevance beyond cancer.